TrialAIDS (London, England)2015

Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.

Anthony R Cillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.